CCL2 and breast carcinoma: Meanwhile, Fang et al. (2012) demonstrated that CCL2 treatment decreased apoptosis caused by serum deprivation, gentamicin or 5-FU treatment in mouse and human mammary carcinoma cells (MDA-MB-231), suggesting that CCL2 may induce pro-survival effects in human breast cancer cells [78].